Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis. Targeting neuroinflammation with small molecules is promising, but ...

Despite past performance issues, Arvinas has a solid cash runway. Learn more about ARVN stock's potential and why a cautious ...

Noah M. Merin, MD, PhD, discusses the mechanisms of action and sequencing of oral therapies for chronic graft-vs-host disease (GVHD) in a live virtual event.

After successful trials, three local drug makers are set to begin full-fledged commercial production of active pharmaceutical ...

Discover the groundbreaking research on microRNA by Nobel Prize winners Ambros and Ruvkun, revolutionizing gene regulation ...

Liquid crystals exist in a phase of their own. They can flow like liquids, but because their molecules are arranged in a ...

Magnetic resonance imaging (MRI) has long been a cornerstone of modern medicine, providing highly detailed images of internal ...

A type of binary-system known as a microquasar has been found to be firing out γ-rays at high energy-levels, which may make ...

Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in ...

Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including ...

A clinical trial will test whether a lab-made version of a molecule found in spider venom can reverse tissue damage after a ...

ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six ...